CD4 is required for the development of a protective granulomatous response to pulmonary tuberculosis
- PMID: 12381351
- DOI: 10.1016/s0008-8749(02)00510-5
CD4 is required for the development of a protective granulomatous response to pulmonary tuberculosis
Abstract
To confirm the primary role of CD4 T cells in pulmonary tuberculosis, mice with a disruption of their CD4 gene (CD4 KO) were exposed to an aerosol of Mycobacterium tuberculosis and survival, cellular responses in the lung and granuloma development followed. CD8 and NK cells from the lungs of infected CD4 KO mice expressed IFN-gamma and were recruited in numbers similar to those seen in the C57BL/6 mice; recruitment correlated with initial control of bacteria. The major defect in mice lacking CD4 was the significant reduction in total cellular recruitment into the lungs. CD4 KO mice did not generate the typical mononuclear granulomatous lesions, instead the cellular influx was macrophage in character and was localized as perivascular cuffing. Early control of M. tuberculosis growth is therefore independent of CD4+ cells but such cells are required to ensure recruitment of mononuclear cells to the lung and thus ensure long-term survival.
Similar articles
-
Induction of Mycobacterium tuberculosis-specific primary and secondary T-cell responses in interleukin-15-deficient mice.Infect Immun. 2005 May;73(5):2910-22. doi: 10.1128/IAI.73.5.2910-2922.2005. Infect Immun. 2005. PMID: 15845497 Free PMC article.
-
CD4+ T cell-dependent IFN-γ production by CD8+ effector T cells in Mycobacterium tuberculosis infection.J Immunol. 2012 Sep 1;189(5):2530-6. doi: 10.4049/jimmunol.1200994. Epub 2012 Jul 25. J Immunol. 2012. PMID: 22837486 Free PMC article.
-
Old mice express a transient early resistance to pulmonary tuberculosis that is mediated by CD8 T cells.Infect Immun. 2002 Aug;70(8):4628-37. doi: 10.1128/IAI.70.8.4628-4637.2002. Infect Immun. 2002. PMID: 12117976 Free PMC article.
-
The host immune response to tuberculosis.Am J Respir Crit Care Med. 1998 Mar;157(3 Pt 1):679-91. doi: 10.1164/ajrccm.157.3.9708002. Am J Respir Crit Care Med. 1998. PMID: 9517576 Review. No abstract available.
-
[Research progress of pulmonary tuberculosis local immune].Zhonghua Jie He He Hu Xi Za Zhi. 2014 Feb;37(2):119-21. Zhonghua Jie He He Hu Xi Za Zhi. 2014. PMID: 24796594 Review. Chinese. No abstract available.
Cited by
-
Immunocyte count combined with CT features for distinguishing pulmonary tuberculoma from malignancy among non-calcified solitary pulmonary solid nodules.J Thorac Dis. 2023 Feb 28;15(2):386-398. doi: 10.21037/jtd-22-1024. Epub 2023 Jan 31. J Thorac Dis. 2023. PMID: 36910060 Free PMC article.
-
Nanoparticle-Fusion Protein Complexes Protect against Mycobacterium tuberculosis Infection.Mol Ther. 2018 Mar 7;26(3):822-833. doi: 10.1016/j.ymthe.2017.12.016. Epub 2017 Dec 22. Mol Ther. 2018. PMID: 29518353 Free PMC article.
-
Exosomes derived from M. Bovis BCG infected macrophages activate antigen-specific CD4+ and CD8+ T cells in vitro and in vivo.PLoS One. 2008 Jun 18;3(6):e2461. doi: 10.1371/journal.pone.0002461. PLoS One. 2008. PMID: 18560543 Free PMC article.
-
An Insight into Advances in Developing Nanotechnology Based Therapeutics, Drug Delivery, Diagnostics and Vaccines: Multidimensional Applications in Tuberculosis Disease Management.Pharmaceuticals (Basel). 2023 Apr 12;16(4):581. doi: 10.3390/ph16040581. Pharmaceuticals (Basel). 2023. PMID: 37111338 Free PMC article. Review.
-
Programmed death-1+ T cells inhibit effector T cells at the pathological site of miliary tuberculosis.Clin Exp Immunol. 2017 Feb;187(2):269-283. doi: 10.1111/cei.12871. Epub 2016 Nov 24. Clin Exp Immunol. 2017. PMID: 27665733 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Molecular Biology Databases
Research Materials
